Who owns Arcus Biosciences, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of RCUS from SEC Form 13F filings across 244 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 244 institutions disclosed 124.9M shares of Arcus Biosciences, Inc. worth $3.23B — about 98.1% of shares outstanding; the largest disclosed holder is GILEAD SCIENCES, INC.. Source: SEC Form 13F filings, parsed by EvidInvest.
244
13F holders
$3.23B
value, 2026 filers
98.1%
of shares outstanding (124.9M sh)
47
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of RCUS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES, INC. | 31.4M | $811.7M | 55.5% | 24.7% | 0.0% |
| 2 | BlackRock, Inc. | 16.8M | $434.6M | 0.0% | 13.2% | +2.5% |
| 3 | WELLINGTON MANAGEMENT GROUP LLP | 6.2M | $159.4M | 0.0% | 4.8% | +4.6% |
| 4 | STATE STREET CORP | 5.6M | $143.9M | 0.0% | 4.4% | -7.6% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.4M | $114.7M | 0.0% | 3.5% | -0.8% |
| 6 | FMR LLC | 4.4M | $114.6M | 0.0% | 3.5% | +9.6% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 3.9M | $101.5M | 0.0% | 3.1% | +1.1% |
| 8 | CITADEL ADVISORS LLC | 3.0M | $76.5M | 0.0% | 2.3% | -5.6% |
| 9 | Woodline Partners LP | 2.9M | $73.7M | 0.2% | 2.2% | -5.1% |
| 10 | Janus Henderson Group Ltd.NEW | 2.5M | $65.6M | 0.0% | 2% | new |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 2.5M | $64.1M | 0.0% | 1.9% | +1.3% |
| 12 | Siren, L.L.C. | 2.4M | $62.5M | 1.5% | 1.9% | 0.0% |
| 13 | Fisher Asset Management, LLC | 1.9M | $49.6M | 0.0% | 1.5% | -10.3% |
| 14 | GOLDMAN SACHS GROUP INC | 1.6M | $42.3M | 0.0% | 1.3% | +18.0% |
| 15 | SAMLYN CAPITAL, LLC | 1.4M | $36.0M | 0.6% | 1.1% | -9.8% |
| 16 | DIMENSIONAL FUND ADVISORS LP | 1.4M | $35.9M | 0.0% | 1.1% | -3.0% |
| 17 | TWO SIGMA INVESTMENTS, LP | 1.3M | $34.3M | 0.0% | 1% | +109.0% |
| 18 | Vestal Point Capital, LPNEW | 1.3M | $33.6M | 0.9% | 1% | new |
| 19 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.2M | $32.1M | 0.0% | 1% | -12.4% |
| 20 | Invesco Ltd. | 1.2M | $30.6M | 0.0% | 0.9% | +40.2% |
| 21 | MORGAN STANLEY | 1.2M | $30.1M | 0.0% | 0.9% | +46.5% |
| 22 | Aberdeen Group plc | 1.1M | $27.3M | 0.0% | 0.8% | +62.4% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 964,691 | $24.9M | 0.0% | 0.8% | +2.4% |
| 24 | NORTHERN TRUST CORP | 930,303 | $24.0M | 0.0% | 0.7% | -0.2% |
| 25 | BANK OF AMERICA CORP /DE/ | 915,248 | $23.6M | 0.0% | 0.7% | +9.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.